Point: Should Paralytic Agents Be Routinely Used in Severe ARDS? Yes

被引：2

作者：

Hall, Jesse B. ^{[1
,2
]}

机构：

[1] Univ Chicago, Dept Anesthesia & Crit Care, Chicago, IL 60637 USA

[2] Univ Chicago, Pulm & Crit Care Med Sect, Pritzker Sch Med, Chicago, IL 60637 USA

来源：

CHEST | 2013年 / 144卷 / 05期

关键词：

RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; END-EXPIRATORY PRESSURE; NEUROMUSCULAR BLOCKING-AGENTS; RANDOMIZED CONTROLLED-TRIAL; TIDAL VOLUMES; VENTILATION;

D O I：

10.1378/chest.13-1460

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：1440 / 1442

页数：3

共 50 条

[21] Prone positioning and neuromuscular blocking agents are part of standard care in severe ARDS patients: yes
Guerin, Claude
Mancebo, Jordi
INTENSIVE CARE MEDICINE, 2015, 41 (12) : 2195 - 2197
[22] Nitric oxide should be used in ARDS
Gerlach, H.
ANAESTHESIA, PAIN, INTENSIVE CARE AND EMERGENCY MEDICINE, 2005, : 419 - 430
[23] POINT: Should Broad-Spectrum Antibiotics Be Routinely Administered to All Patients With Sepsis as Soon as Possible? Yes
Disselkamp, Margaret
Yataco, Angel O. Coz
Simpson, Steven Q.
CHEST, 2019, 156 (04) : 645 - 647
[24] The microlaparoscope should be used routinely for diagnostic laparoscopy
Kovacs, GT
Baker, G
Dillon, M
Peters, M
FERTILITY AND STERILITY, 1998, 70 (04) : 698 - 701
[25] PROPHYLAXIS FOR GENITAL HERPES - SHOULD IT BE USED ROUTINELY
MINDEL, A
DRUGS, 1991, 41 (03) : 319 - 325
[26] Rescue therapy for refractory ARDS should be offered early: yes
Alain Combes
Marco Ranieri
Intensive Care Medicine, 2015, 41 : 923 - 925
[27] Rescue therapy for refractory ARDS should be offered early: yes
Combes, Alain
Ranieri, Marco
INTENSIVE CARE MEDICINE, 2015, 41 (05) : 923 - 925
[28] Should a radiological diagnosis of hepatocellular carcinoma be routinely confirmed by a biopsy? Yes
Parisi, Giancarlo
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2012, 23 (01) : 34 - 36
[29] Should physicians routinely be involved in the care of elderly surgical patients? Yes
Wilkinson, Kathy
Wilson, Helen
BMJ-BRITISH MEDICAL JOURNAL, 2011, 342
[30] POINT: Should Molecular and Genetic Biomarkers Be Used in the Initial Evaluation of Patients With Fibrotic ILD? Yes
Prasse, Antje
CHEST, 2019, 156 (02) : 203 - 205

← 1 2 3 4 5 →